Lack of knowledge on the use of doxycycline hyclate in human medicine is a significant public health issue and contributes to the increase of antibiotic resistance. Doxycycline hyclate is a tetracycline antibiotic with a broad-spectrum bactericidal activity. However, knowledge about doxycycline hyclate use in human medicine is limited. In this study, we aimed to evaluate the knowledge about doxycycline hyclate use in human medicine and the impact of drug resistance on the use of this antibiotic in the country. We collected the records of people who used doxycycline hyclate during the study period in the United Arab Emirates, Saudi Arabia. We evaluated the prevalence of antibiotic resistance and the proportion of antibiotic treatment failures in the period. The analysis included the following data: information on antibiotic resistance, antibiotic treatment failures, antimicrobial resistance, antibiotic prescribing patterns, and antibiotic resistance trends.
All patients who were prescribed doxycycline hyclate as an oral antibiotic were included in the study. Patients who were diagnosed with pneumonia were excluded from the study. We used the same criteria as in our previous study. We defined a patient as a person who had been prescribed doxycycline hyclate in any form for at least one year and had a history of treatment failure. We defined a patient as a person who had been prescribed doxycycline hyclate in any form for at least one month and had a history of treatment failure.
We conducted a retrospective study using the database of the medical and surgical outpatient department of the University of Medicine and Medical Sciences, Dubai. We included patients who were prescribed doxycycline hyclate in any form for at least one month. Patients who were prescribed doxycycline hyclate were followed in the outpatient department for 3 months (1st and 2nd) before initiating the treatment with the following antibiotics: tetracycline, erythromycin, doxycycline, minocycline, oxytetracycline, doxycycline monohydrate, doxycycline hyclate monohydrate and doxycycline hyclate monohydrate. We recorded the prescription records for the patients in the outpatient department of the University of Medicine and Medical Sciences, Dubai. We included patients who did not receive treatment with tetracycline and erythromycin at the outpatient department of the University of Medicine and Medical Sciences, Dubai. We included patients who received antibiotics for the same time period. We assessed the antibiotic resistance and the proportion of antibiotic treatment failures in the period. We used the data from the Department of Clinical Microbiology and Infectious Diseases, Dubai. The data were obtained from the Department of Clinical Microbiology and Infectious Diseases, University of Medicine and Medical Sciences, Dubai. We used the data from the Department of Clinical Microbiology and Infectious Diseases, University of Medicine and Medical Sciences, Dubai.
We obtained ethics approval from the Institutional Review Board of the University of Medicine and Medical Sciences, Dubai for this study. Informed consent was obtained from all participants before obtaining the consent form.
From the outpatient department of the University of Medicine and Medical Sciences, Dubai, we identified a total of 474 patients who received doxycycline hyclate. The majority of patients used doxycycline hyclate as a treatment for pneumonia and had a history of treatment failure. The majority of patients had no history of treatment failure at the time of initiating the antibiotic. We recorded antibiotic resistance in the period of 1st and 2nd month and antibiotic treatment failures in the period of 3rd and 4th month. The mean antibiotic treatment failures were: tetracycline monohydrate: 0.7%, doxycycline monohydrate: 1.2%, doxycycline hyclate monohydrate: 1.3%, and doxycycline monohydrate: 1.8%.
The present study investigated the knowledge of doxycycline hyclate use in human medicine and found that the majority of the patients had a history of treatment failure. The antibiotic resistance was found to be higher in the period of 2nd month and 3rd month.
The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser.For the best experience on our site, be sure to turn on Javascript in your browser.
Common Name: Doxycycline hyclate 100 mg Oral Capsule
Dosage strength: 1 Capsule
This medication is a combination of two medications: doxycycline and amoxicillin. Doxycycline and amoxicillin work by inhibiting the growth of bacteria. Doxycycline is used to treat a wide variety of bacterial infections. Amoxicillin is a penicillin-type antibiotic. Doxycycline is effective against many anaerobic bacteria. This medication is used to treat various infections, including those that affect the heart, bones, joints, skin, or kidney. Doxycycline is not a cure and only treats "mine" or "super" infections. It will not work for viral infections or those that are resistant to many other antibiotics. This medication is a quick-doping antibiotic. It will not work for viral infections or those that are not treated properly. If you cannot use doxycycline hyclate, you do not have the bacteria causing the infection. Doxycycline hyclate is a yellow to dark yellow to off-white pill. It is available in: capsules,oral solution, oral tablet, and generic. The active ingredients in this medication are doxycycline and amoxicillin. The capsules have a white, pill-like shell. The solution has a pungent, odorless, and grain-colored FDA-approved taste. The tablets have a white to off-white base, which allows for absorption. This medication is available in 250 mg, 500 mg, or 1 gram tablet. Generic medication may vary.
Should have 14-days in which to use this medicationDoxycycline Hyclate 100 mg Oral Capsule is used to treat a wide range of bacterial infections, including:
This medication is also used to treat anaerobic bacterial infections, including:
This medication is also sometimes used to treat infections of the blood, nervous system, muscle, and joints.
This medication may be used as part of a combination therapy with other medications. Doxycycline Hyclate 100 mg Oral Capsule may also be used to treat other types of infections, like urinary tract infections, respiratory tract infections, and skin infections.
Can I take doxycycline hyclate if I am pregnant? If you are pregnant, please do not take doxycycline hyclate.Doxycycline Hyclate 100 mg Oral Capsule should not be used during pregnancy. It can harm your unborn baby. Doxycycline Hyclate 100 mg Oral Capsule should not be used in pregnant women.
Doxycycline Hyclate 100 mg Oral Capsule is not recommended for use in children under the age of 12.
This drug should not be used during pregnancy. Doxycycline Hyclate 100 mg Oral Capsule may harm your unborn baby. Do not take doxycycline hyclate while using this medication in your unborn child.
This medication should not be used during pregnancy.
Avoid taking doxycycline hyclate with grapefruit juice as it may increase the risk of side effects. Talk to your doctor about the risks and benefits of using this drug.
Doxycycline Hyclate 100 mg Oral Capsule is not approved for use in adults. It may be prescribed in children under the age of 12. Doxycycline Hyclate 100 mg Oral Capsule should not be used to treat bacterial infections in pediatric patients age 12 and under.
Doxycycline Hyclate 100 mg Oral Capsule should not be used in infants or children below 12 years of age.
This medication should not be used in children or adolescents under 12 years of age.
This medication should not be used to treat anaerobic bacterial infections, including:
It is also not approved for use in children under the age of 12.
We understand that you may have a lot of questions about starting a new medication and whether it will work or help you feel better. You’re not alone; many patients feel the same way.
There are many different factors that influence how well you respond to a medication. Keep in mind that some medications work better for certain people than others, and that’s because each person is different—genetics, age, and gender, among other differences—all affect how someone responds to treatment. Other factors such as underlying health conditions, other medications, and dietary considerations can also play a role in how a medication works.
Remember, your response to Doxycycline (Oral) may be different from someone else’s response At Brightside, we can help you find the right medication to help you feel better. Before starting any new medication like Doxycycline (Oral), you should get a comprehensive health assessment from a provider who understands your health history. You should only take this medication if you’ve been diagnosed with a serious health condition and—at Brightside’s cost—are aged 65 or older, demonstrate a risk of progression to bacterial resistant bacteria, and have a suitable dosage of Doxycycline (Oral) are all safe and effective choices.
Whether you are a woman who is pregnant or a men who are considering becoming pregnant, getting advice from a healthcare provider is key. We can support you on the use of safe medications, the importance of bacterialpeciallyzyme 101tested medications, and more. By being prepared and accurate, you can make sure you’re feeling the best you’ve ever been for a reason that’s not old or hasn’t been assessed before.
Doxycycline (Oral) is an antibiotic that is used to treat various infections. It works by stopping the growth of bacteria. It will not work for colds or other infections that’s caused by the beta-lactamase inhibitor penicillin.It’s important to know that Doxycycline (Oral) only works for susceptible bacteria, not all resistant organisms. You should not take Doxycycline (Oral) if you’re pregnant, if you’re planning a pregnancy or if you’re breastfeeding. You should not take Doxycycline (Oral) if you are allergic to it or to penicillin or cephalosporin antibiotics.
When you take Doxycycline (Oral), you’ll get the benefits it’s been designed to offer. When you take Doxycycline (Oral), you’ll experience some resistance; when you take Doxycycline (Oral), you’re unlikely to experience the same benefits.
If you are taking an antibiotic that is used to treat a certain infection, like ciprofloxacin (Cipro), levofloxacin (Levaquin, not available in the United States), ofloxacin (Vemanity), or tetracycline (Amistadine, not available in the United States, are all antibiotic medications that may help treat your symptoms.
At Brightside, we can prescribe either of these medications if you’re eligible and you’re diagnosed with bacterial resistant infections.At Brightside, we prescribe both Doxycycline (Oral) and levofloxacin (ichever is the first medication), depending on your needs and the severity of your bacterial infection. If you are eligible to take our healthcare provider’s assessment, you should not take Doxycycline (Oral) without getting a comprehensive health review from a provider who is aware of your health history. If you are not, you should not take our medication.
To make the most of our trusted medications, we’ve evaluated several factors before prescribing you. From the type of infection you’re treated for to the types of symptoms you may suffer from, our provider-recommended types are available at Brightside’s prices and at.
Doxycycline is an antibiotic that is used to treat various infections.
It is not recommended for use by children. However, it is not unlikely that a patient may become pregnant. Vaginal use is not recommended while pregnant unless the potential benefits are strong. Doxycycline may pass through breast milk to patient milk, so we only prescribe it if a doctor has assessed your health history before prescribing.
It should not be taken by children.
Nathan M, Rosen RH, Mohn E, et al. The effects of doxycycline on doxycycline hyclate pharmacokinetics.J Clin Pharmacol2007;60:9–16.
Mangalee M, Bhatia N, Kumar N, et al. Pharmacokinetics of doxycycline in healthy volunteers.Int J Clin Pharmacol2008;31:3–7.
Rosen RH, Tariq A, Rosen RH, et al. Pharmacokinetic analysis of doxycycline in aqueous solution of human milk.Drug Metabolism2007;36:1388–93.
Gossen D, Haldeman M, Felson M, et al.2009;61:6–12.
Haldeman M, Felson M, Haldeman M, et al. Pharmacokinetics of doxycycline in healthy volunteers: pharmacokinetics of doxycycline hydrochloride in humans.2009;31:1387–92.
Javanese D, Haldeman M, Felson M, et al.2008;61:1582–90.
Bhatia N, Rosen RH, Felson M, et al. Pharmacokinetics of doxycycline in healthy volunteers: pharmacokinetic study.2007;36:1409–21.
Arya M, Bhatia N, Rosen RH, et al.2007;61:1088–91.
Felson M, Haldeman M, Rosen RH, et al. Pharmacokinetic analysis of doxycycline in healthy volunteers.2007;61:1587–91.
Rosen RH, Arya M, Felson M, et al.2008;61:1598–201.
Kaufman M, Rosen RH, Rosen RH, et al.2008;61:1135–42.
Rosen RH, Haldeman M, Rosen RH, et al.2007;36:2225–28.
Bhatia N, Rosen RH, Haldeman M, et al. Pharmacokinetic analysis of doxycycline in healthy volunteers: pharmacokinetic study.
2007;61:1598–201.
2008;61:1588–91.
Haldeman M, Rosen RH, Rosen RH, et al.2007;36:2224–30.
Rosen RH, Felson M, Haldeman M, et al.
Stade de France Pharmacy